THE DEAL, AT A GLANCE
From the announcementNewLimit
01Who is involvedBacked by Brian ArmstrongFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedNewLimit raised $435M Series C, announced 2026-06-23From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersNewLimit is a longevity biotech company using a $435M Series C to pursue a capital-intensive biotechnology strategy in a sector where value creation likely depends on…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
NewLimit · Financing Record
Explore source-linked visual explanations for NewLimit. Unsupported claims are withheld while source review continues.
Record 8986 · Recorded date: 2026-06-23
Explore company records →